Norrby, M., Vesikari, T., Lindqvist, L., Maeurer, M., Ahmed, R., Mahdavifar, S., Bennett, S., McClain, J. B., Shepherd, B. M., Li, D., Hokey, D. A., Kromann, I., Hoff, S. T., Andersen, P., de Visser, A. W., Joosten, S. A., Ottenhoff, T. H., Andersson, J., & Brighenti, S. (2017). safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials. Vaccine, 35(12), 1652–1661. http://access.bl.uk/ark:/81055/vdc_100045079124.0x000054